{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:49:35Z","timestamp":1788929375230,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.gme.0000240633.46300.fa","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T05:04:19Z","timestamp":1155099859000},"page":"780-786","source":"Crossref","is-referenced-by-count":116,"title":["Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women"],"prefix":"10.1097","volume":"13","author":[{"given":"Claudio N.","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Arsenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadine","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Bankier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210227","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00002512-200118080-00004","article-title":"Hot flashes: aetiology and management.","volume":"18","author":"Barton","year":"2001","journal-title":"Drugs Aging"},{"key":"R2-12-20210227","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-3999(97)00126-8","article-title":"Sleep disruption and mood changes associated with menopause.","volume":"43","author":"Baker","year":"1997","journal-title":"J Psychosom Res"},{"key":"R3-12-20210227","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8545(21)00635-5","article-title":"Evaluation and treatment of changes in mood, sleep, and sexual functioning associated with menopause.","volume":"21","author":"Stone","year":"1994","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R4-12-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5122(86)90029-0","article-title":"Relationships between psychological symptoms, somatic complaints and menopausal status.","volume":"8","author":"Hunter","year":"1986","journal-title":"Maturitas"},{"key":"R5-12-20210227","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S8756-3282(02)00778-0","article-title":"Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures.","volume":"31","author":"Fiorano-Charlier","year":"2002","journal-title":"Bone"},{"key":"R6-12-20210227","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","article-title":"Postmenopausal hormone therapy and mortality.","volume":"336","author":"Grodstein","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-12-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-7091-6139-5_21","article-title":"Can estrogen play a significant role in the prevention of Alzheimer's disease?","volume":"62","author":"Kesslak","year":"2002","journal-title":"J Neural Transm Suppl"},{"key":"R8-12-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-5122(02)00038-5","article-title":"Menopausal transition and increased depressive symptomatology: a community based prospective study.","volume":"42","author":"Maartens","year":"2002","journal-title":"Maturitas"},{"key":"R9-12-20210227","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2105\/AJPH.91.9.1435","article-title":"Psychologic distress and natural menopause: a multiethnic community study.","volume":"91","author":"Bromberger","year":"2001","journal-title":"Am J Public Health"},{"key":"R10-12-20210227","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.61.1.62","article-title":"Hormones and menopausal status as predictors of depression in women in transition to menopause.","volume":"61","author":"Freeman","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R11-12-20210227","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1176\/appi.ajp.161.12.2238","article-title":"A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women.","volume":"161","author":"Schmidt","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R12-12-20210227","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archpsyc.63.4.385","article-title":"Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.","volume":"63","author":"Cohen","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R13-12-20210227","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.287.5.591","article-title":"Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen\/Progestin Replacement Study (HERS) trial.","volume":"287","author":"Hlatky","year":"2002","journal-title":"JAMA"},{"key":"R14-12-20210227","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2000.106004","article-title":"Estrogen replacement in perimenopause-related depression: a preliminary report.","volume":"183","author":"Schmidt","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R15-12-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","article-title":"Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.","volume":"58","author":"Soares","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R16-12-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R17-12-20210227","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"R18-12-20210227","first-page":"64","article-title":"Alternatives to HRT: an evidence-based review.","volume":"48","author":"Taylor","year":"2003","journal-title":"Int J Fertil Womens Med"},{"key":"R19-12-20210227","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/152460901317193576","article-title":"An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy.","volume":"10","author":"Joffe","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"R20-12-20210227","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4088\/JCP.v64n0419","article-title":"Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.","volume":"64","author":"Soares","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R21-12-20210227","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"issue":"suppl 20","key":"R22-12-20210227","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R23-12-20210227","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R24-12-20210227","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climacteric scale.","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"key":"R25-12-20210227","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00042192-200105000-00007","article-title":"Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors.","volume":"8","author":"Carpenter","year":"2001","journal-title":"Menopause"},{"key":"R26-12-20210227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-5122(96)01038-9","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties.","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"key":"R27-12-20210227","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"R28-12-20210227","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/da.20051","article-title":"Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting.","volume":"21","author":"Rush","year":"2005","journal-title":"Depress Anxiety"},{"key":"R29-12-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00023210-200317050-00004","article-title":"Escitalopram: a review of its use in the management of major depressive and anxiety disorders.","volume":"17","author":"Waugh","year":"2003","journal-title":"CNS Drugs"},{"key":"R30-12-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-0327(98)00203-1","article-title":"Fluoxetine efficacy in menopausal women with and without estrogen replacement.","volume":"55","author":"Amsterdam","year":"1999","journal-title":"J Affect Disord"},{"key":"R31-12-20210227","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00737-004-0051-y","article-title":"Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.","volume":"7","author":"Cassano","year":"2004","journal-title":"Arch Women Ment Health"},{"key":"R32-12-20210227","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"key":"R33-12-20210227","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jwh.2005.14.609","article-title":"Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.","volume":"14","author":"Thase","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"R34-12-20210227","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2003.08.011","article-title":"Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.","volume":"55","author":"Morrison","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R35-12-20210227","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.maturitas.2003.10.003","article-title":"A comparison of the central effects of different progestins used in hormone replacement therapy.","volume":"48","author":"Cagnacci","year":"2004","journal-title":"Maturitas"},{"key":"R36-12-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-5122(02)00333-X","article-title":"The clinical practice impact of the Women's Health Initiative: political vs biologic correctness.","volume":"44","author":"Notelovitz","year":"2003","journal-title":"Maturitas"},{"key":"R37-12-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.GME.0000097742.96468.68","article-title":"A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms.","volume":"11","author":"Botteman","year":"2004","journal-title":"Menopause"},{"key":"R38-12-20210227","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5122(00)00152-3","article-title":"Treatment of hot flushes with mirtazapine: four case reports.","volume":"36","author":"Waldinger","year":"2000","journal-title":"Maturitas"},{"key":"R39-12-20210227","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes.","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"R40-12-20210227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R41-12-20210227","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/da.20085","article-title":"Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.","volume":"22","author":"Ladd","year":"2005","journal-title":"Depress Anxiety"},{"key":"R42-12-20210227","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hup.694","article-title":"The effect of escitalopram on sleep problems in depressed patients.","volume":"20","author":"Lader","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"Suppl 16","key":"R43-12-20210227","first-page":"27","article-title":"Daytime sleepiness and insomnia as correlates of depression.","volume":"65","author":"Fava","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R44-12-20210227","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00042192-200007020-00003","article-title":"A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.","volume":"7","year":"2000","journal-title":"Menopause"},{"key":"R45-12-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1503\/cmaj.1040517","article-title":"Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship.","volume":"172","author":"McIntyre","year":"2005","journal-title":"CMAJ"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200613050-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:40:03Z","timestamp":1785858003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200613050-00012"}},"subtitle":["impact on depression, vasomotor symptoms, sleep, and quality of life"],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gme.0000240633.46300.fa","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}